PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a 
healthier world, announced today that the U.S. Food and Drug Administration 
(FDA) has provided Emergency Use Authorization (EUA) for the Company's New 
Coronavirus RT-PCR test. Clinical laboratories certified under Clinical 
Laboratory Improvement Amendments (CLIA) can immediately begin using this kit 
to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer's RT-PCR test 
is marketed as an in vitro diagnostic (IVD) device by meeting the requirements 
of the European In Vitro Diagnostic Directive (IVDD) and is available in over 
30 countries worldwide.

https://photos.prnasia.com/prnh/20200325/2760526-1

(Caption: PerkinElmer's New Coronavirus RT-PCR test)

"Despite the challenging environment, our employees have demonstrated 
unwavering commitment over the past two months to combat this global pandemic," 
said Prahlad Singh, president and chief executive officer, PerkinElmer. "The 
breadth of PerkinElmer's total workflow solution puts us in a unique position 
to rapidly address the needs of our clinical diagnostics customers."

About PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their 
most critical challenges across science and healthcare. With a mission focused 
on innovating for a healthier world, we deliver unique solutions to serve the 
diagnostics, life sciences, food and applied markets. We strategically partner 
with customers to enable earlier and more accurate insights supported by deep 
market knowledge and technical expertise. Our dedicated team of about 13,000 
employees worldwide is passionate about helping customers work to create 
healthier families, improve the quality of life, and sustain the wellbeing and 
longevity of people globally. The Company reported revenue of approximately 
$2.9 billion in 2019, serves customers in 190 countries, and is a component of 
the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, 
or at www.perkinelmer.com.

More information can be found on PerkinElmer's official website: 

http://ir.perkinelmer.com/news-releases/news-release-details/fda-provides-emergency-use-authorization-perkinelmer-covid-19


Source: PerkinElmer, Inc. 


Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=360562

   Caption: PerkinElmer's New Coronavirus RT-PCR test